Casdin Capital, LLC Diversified Active

CIK: 0001534261 · Show all filings

Period: Q2 2017 (← Previous) (Next →)

Filing Date: Aug 14, 2017

Total Value ($000): $270,353 (100.0% shares, 0.0% debt)

Holdings (35)

— LOXO ONCOLOGY INC 10.7%

Value ($000) $28,868 Shares 360,000 Est. Cost $28.44 Unrealized —

— SAGE THERAPEUTICS INC 7.5%

Value ($000) $20,308 Shares 255,000 Est. Cost $47.85 Unrealized —

— FOUNDATION MEDICINE INC 7.1%

Value ($000) $19,080 Shares 480,000 Est. Cost $18.96 Unrealized —

— BLUEPRINT MEDICINES CORP 5.2%

Value ($000) $13,934 Shares 275,000 Est. Cost $28.38 Unrealized —

EVH EVOLENT HEALTH INC 4.9%

Value ($000) $13,182 Shares 520,000 Est. Cost $18.09 Unrealized +33.0%

AGIO AGIOS PHARMACEUTICALS INC 4.9%

Value ($000) $13,120 Shares 255,000 Est. Cost $51.71 Unrealized -1.1%

SGMO SANGAMO THERAPEUTICS INC 4.6%

Value ($000) $12,320 Shares 1,400,000 Est. Cost $4.96 Unrealized +29.5%

— CLOVIS ONCOLOGY INC 4.5%

Value ($000) $12,172 Shares 130,000 Est. Cost $88.33 Unrealized —

XBI SPDR SERIES TRUST 4.3%

Value ($000) $11,577 Shares 150,000 Est. Cost — Unrealized —

— SPARK THERAPEUTICS INC 3.8%

Value ($000) $10,156 Shares 170,000 Est. Cost $48.26 Unrealized —

— KITE PHARMA INC 3.5%

Value ($000) $9,330 Shares 90,000 Est. Cost $79.54 Unrealized —

ALNY ALNYLAM PHARMACEUTICALS INC 3.1%

Value ($000) $8,375 Shares 105,000 Est. Cost $62.48 Unrealized +2.3%

— GENMARK DIAGNOSTICS INC 3.0%

Value ($000) $8,104 Shares 685,000 Est. Cost $10.61 Unrealized —

— EPIZYME INC 2.9%

Value ($000) $7,852 Shares 520,000 Est. Cost $15.61 Unrealized —

— AUDENTES THERAPEUTICS INC 2.8%

Value ($000) $7,652 Shares 400,000 Est. Cost $17.77 Unrealized —

— BLUEBIRD BIO INC 2.5%

Value ($000) $6,828 Shares 65,000 Est. Cost $87.63 Unrealized —

— TESARO INC 2.5%

Value ($000) $6,713 Shares 48,000 Est. Cost $144.97 Unrealized —

VYGR VOYAGER THERAPEUTICS INC 2.5%

Value ($000) $6,630 Shares 740,000 Est. Cost $13.53 Unrealized —

CDXS CODEXIS INC 2.4%

Value ($000) $6,486 Shares 1,190,000 Est. Cost $4.57 Unrealized +0.5%

— GLOBAL BLOOD THERAPEUTICS IN 2.2%

Value ($000) $5,880 Shares 215,000 Est. Cost $22.92 Unrealized —

ILMN ILLUMINA INC 2.0%

Value ($000) $5,466 Shares 31,500 Est. Cost $173.03 Unrealized 0.0%

GILD GILEAD SCIENCES INC 2.0%

Value ($000) $5,309 Shares 75,000 Est. Cost $48.32 Unrealized 0.0%

— MYOKARDIA INC 1.9%

Value ($000) $5,175 Shares 395,000 Est. Cost $13.45 Unrealized —

GILD GILEAD SCIENCES INC 1.6%

Value ($000) $4,247 Shares 60,000 Est. Cost $48.32 Unrealized 0.0%

— SYROS PHARMACEUTICALS INC 1.1%

Value ($000) $2,931 Shares 182,141 Est. Cost $13.81 Unrealized —

CTMX CYTOMX THERAPEUTICS INC 1.0%

Value ($000) $2,751 Shares 177,500 Est. Cost $15.07 Unrealized +0.0%

MYGN MYRIAD GENETICS INC 1.0%

Value ($000) $2,584 Shares 100,000 Est. Cost — Unrealized —

OVID OVID THERAPEUTICS INC 0.9%

Value ($000) $2,326 Shares 221,700 Est. Cost $13.06 Unrealized 0.0%

— JOUNCE THERAPEUTICS INC 0.8%

Value ($000) $2,245 Shares 160,000 Est. Cost $20.50 Unrealized —

EDIT EDITAS MEDICINE INC 0.8%

Value ($000) $2,237 Shares 133,333 Est. Cost $20.61 Unrealized -12.6%

MDRX ALLSCRIPTS HEALTHCARE SOLUTN 0.7%

Value ($000) $1,914 Shares 150,000 Est. Cost $12.72 Unrealized -4.5%

FATE FATE THERAPEUTICS INC 0.7%

Value ($000) $1,782 Shares 550,000 Est. Cost $3.83 Unrealized 0.0%

— AMYRIS INC 0.6%

Value ($000) $1,590 Shares 500,000 Est. Cost $3.18 Unrealized —

PACB PACIFIC BIOSCIENCES CALIF IN 0.4%

Value ($000) $1,068 Shares 300,000 Est. Cost $4.89 Unrealized -17.6%

— CURIS INC 0.1%

Value ($000) $161 Shares 85,000 Est. Cost $2.78 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	LOXO ONCOLOGY INC	360,000	$28,868	10.7%	$28.44	—	COM	548862101
—	SAGE THERAPEUTICS INC	255,000	$20,308	7.5%	$47.85	—	COM	78667J108
—	FOUNDATION MEDICINE INC	480,000	$19,080	7.1%	$18.96	—	COM	350465100
—	BLUEPRINT MEDICINES CORP	275,000	$13,934	5.2%	$28.38	—	COM	09627Y109
EVH	EVOLENT HEALTH INC	520,000	$13,182	4.9%	$18.09	+33.0%	CL A	30050B101
AGIO	AGIOS PHARMACEUTICALS INC	255,000	$13,120	4.9%	$51.71	-1.1%	COM	00847X104
SGMO	SANGAMO THERAPEUTICS INC	1,400,000	$12,320	4.6%	$4.96	+29.5%	COM	800677106
—	CLOVIS ONCOLOGY INC	130,000	$12,172	4.5%	$88.33	—	COM	189464100
XBI	SPDR SERIES TRUST	150,000	$11,577	4.3%	—	—	Put	78464A870
—	SPARK THERAPEUTICS INC	170,000	$10,156	3.8%	$48.26	—	COM	84652J103
—	KITE PHARMA INC	90,000	$9,330	3.5%	$79.54	—	COM	49803L109
ALNY	ALNYLAM PHARMACEUTICALS INC	105,000	$8,375	3.1%	$62.48	+2.3%	COM	02043Q107
—	GENMARK DIAGNOSTICS INC	685,000	$8,104	3.0%	$10.61	—	COM	372309104
—	EPIZYME INC	520,000	$7,852	2.9%	$15.61	—	COM	29428V104
—	AUDENTES THERAPEUTICS INC	400,000	$7,652	2.8%	$17.77	—	COM	05070R104
—	BLUEBIRD BIO INC	65,000	$6,828	2.5%	$87.63	—	COM	09609G100
—	TESARO INC	48,000	$6,713	2.5%	$144.97	—	COM	881569107
VYGR	VOYAGER THERAPEUTICS INC	740,000	$6,630	2.5%	$13.53	—	COM	92915B106
CDXS	CODEXIS INC	1,190,000	$6,486	2.4%	$4.57	+0.5%	COM	192005106
—	GLOBAL BLOOD THERAPEUTICS IN	215,000	$5,880	2.2%	$22.92	—	COM	37890U108
ILMN	ILLUMINA INC	31,500	$5,466	2.0%	$173.03	0.0%	COM	452327109
GILD	GILEAD SCIENCES INC	75,000	$5,309	2.0%	$48.32	0.0%	COM	375558103
—	MYOKARDIA INC	395,000	$5,175	1.9%	$13.45	—	COM	62857M105
GILD	GILEAD SCIENCES INC	60,000	$4,247	1.6%	$48.32	0.0%	Call	375558103
—	SYROS PHARMACEUTICALS INC	182,141	$2,931	1.1%	$13.81	—	COM	87184Q107
CTMX	CYTOMX THERAPEUTICS INC	177,500	$2,751	1.0%	$15.07	+0.0%	COM	23284F105
MYGN	MYRIAD GENETICS INC	100,000	$2,584	1.0%	—	—	Call	62855J104
OVID	OVID THERAPEUTICS INC	221,700	$2,326	0.9%	$13.06	0.0%	COM	690469101
—	JOUNCE THERAPEUTICS INC	160,000	$2,245	0.8%	$20.50	—	COM	481116101
EDIT	EDITAS MEDICINE INC	133,333	$2,237	0.8%	$20.61	-12.6%	COM	28106W103
MDRX	ALLSCRIPTS HEALTHCARE SOLUTN	150,000	$1,914	0.7%	$12.72	-4.5%	Call	01988P108
FATE	FATE THERAPEUTICS INC	550,000	$1,782	0.7%	$3.83	0.0%	COM	31189P102
—	AMYRIS INC	500,000	$1,590	0.6%	$3.18	—	COM NEW	03236M200
PACB	PACIFIC BIOSCIENCES CALIF IN	300,000	$1,068	0.4%	$4.89	-17.6%	COM	69404D108
—	CURIS INC	85,000	$161	0.1%	$2.78	—	COM	231269101